D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$408M |
| 2 |
Medtronic
MDT
|
+$271M |
| 3 |
NXP Semiconductors
NXPI
|
+$270M |
| 4 |
Gilead Sciences
GILD
|
+$253M |
| 5 |
Hewlett Packard
HPE
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$424M |
| 2 |
CVS Health
CVS
|
+$391M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
+$323M |
| 4 |
Wells Fargo
WFC
|
+$280M |
| 5 |
VMW
VMware, Inc
VMW
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.54% |
| 2 | Healthcare | 10.14% |
| 3 | Financials | 8.94% |
| 4 | Consumer Discretionary | 8.18% |
| 5 | Industrials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1901
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.18M | ﹤0.01% |
49,000
+40,000
| +444% | +$1.41M |
|
|
EGIO
1902
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.18M | ﹤0.01% |
21,588
+528
| +3% | +$44.8K |
|
|
SCMP
1903
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $2.18M | ﹤0.01% |
160,559
+58,058
| +57% | +$810K |
|
1904
PUT
Credit Acceptance
CACC
$5.84B
| $2.17M | ﹤0.01% |
+10,000
| New | +$1.94M |
|
1905
Curis
CRIS
$9.34M
| $2.17M | ﹤0.01% |
353
+107
| +43% | +$643K |
|
1906
Applied Optoelectronics
AAOI
$7.04B
| $2.17M | ﹤0.01% |
92,658
-6,018
| -6% | -$139K |
|
1907
McGrath RentCorp
MGRC
$2.97B
| $2.17M | ﹤0.01% |
55,370
+16,715
| +43% | +$583K |
|
1908
Becton Dickinson
BDX
$45.5B
| $2.17M | ﹤0.01% |
+13,413
| New | +$2.23M |
|
|
WLL
1909
CALL
DELISTED
Whiting Petroleum Corporation
WLL
| $2.16M | ﹤0.01% |
600
+500
| +500% | +$1.5M |
|
1910
Santander
BSBR
$41.4B
| $2.16M | ﹤0.01% |
253,913
+83,885
| +49% | +$630K |
|
1911
Clarus
CLAR
$127M
| $2.16M | ﹤0.01% |
405,590
-4,624
| -1% | -$25.8K |
|
|
BBBY
1912
DELISTED
Bed Bath & Beyond Inc
BBBY
| $2.16M | ﹤0.01% |
53,104
+5,027
| +10% | +$218K |
|
|
PDS
1913
Precision Drilling
PDS
$1.02B
| $2.16M | ﹤0.01% |
+19,791
| New | +$1.95M |
|
1914
Texas Capital Bancshares
TCBI
$4.31B
| $2.15M | ﹤0.01% |
27,432
-16,691
| -38% | -$1.13M |
|
|
CRCM
1915
DELISTED
CARE.COM, INC.
CRCM
| $2.14M | ﹤0.01% |
250,248
+37,104
| +17% | +$326K |
|
1916
CALL
Electronic Arts
EA
$52.4B
| $2.14M | ﹤0.01% |
+27,200
| New | +$2.19M |
|
|
SRCL
1917
DELISTED
Stericycle Inc
SRCL
| $2.14M | ﹤0.01% |
27,780
+14,078
| +103% | +$1.06M |
|
|
HZN
1918
DELISTED
Horizon Global Corporation
HZN
| $2.14M | ﹤0.01% |
89,068
-8,252
| -8% | -$186K |
|
1919
Heritage Financial
HFWA
$1.22B
| $2.12M | ﹤0.01% |
82,487
+32,560
| +65% | +$696K |
|
1920
iShares Biotechnology ETF
IBB
$9.51B
| $2.12M | ﹤0.01% |
+24,000
| New | +$2.18M |
|
|
MJN
1921
PUT
DELISTED
Mead Johnson Nutrition Company
MJN
| $2.12M | ﹤0.01% |
30,000
| – | – |
|
|
CLDT
1922
Chatham Lodging
CLDT
$631M
| $2.12M | ﹤0.01% |
103,283
+34,220
| +50% | +$658K |
|
1923
Core Laboratories
CLB
$503M
| $2.12M | ﹤0.01% |
17,664
-5,536
| -24% | -$613K |
|
1924
Foster
FSTR
$446M
| $2.12M | ﹤0.01% |
155,502
-11,088
| -7% | -$144K |
|
1925
PUT
Lam Research
LRCX
$336B
| $2.12M | ﹤0.01% |
200,000
| – | – |
|
Similar funds
D.E. Shaw & Co's Q4 2016 Portfolio in Review
As of Q4 2016, D.E. Shaw & Co held 3,804 positions worth $58.9B, up 3.9% from $56.7B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
D.E. Shaw & Co's Q4 2016 filing shows 462 new, 1,382 increased, 1,255 reduced and 397 closed positions. Its largest new stake was Deere & Co: 1,429,259 shares worth $147M. The largest sale was Amazon, an estimated $424M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2016 buy was Deere & Co: 1,429,259 shares worth $147M.
- D.E. Shaw & Co added most to Netflix in Q4 2016, an estimated $408M increase.
- D.E. Shaw & Co's biggest Q4 2016 reduction was Amazon, cutting an estimated $424M.
- D.E. Shaw & Co fully exited LinkedIn Corporation in Q4 2016, selling an estimated $323M.
- D.E. Shaw & Co's ten largest holdings make up 8.8% of its $58.9B portfolio in Q4 2016.
- D.E. Shaw & Co opened 462 new positions and closed 397 in Q4 2016.
- D.E. Shaw & Co's portfolio value rose 3.9% quarter-over-quarter to $58.9B.
Based on D.E. Shaw & Co's 13F filing for Q4 2016, filed 14 Feb 2017.